Ayun Kotokai Cassell

Dr. Ayun Kotokai Cassell

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in World Journal of Oncology
Verified
Journal Article
Open access
PDF file
Ayun Kotokai CassellAyun Kotokai Cassell
Ayun Kotokai Cassell
BYBashir Yunusa
Bashir Yunusa
MJMohamed Jalloh
Mohamed Jalloh
MMMouhamadou M. Mbodji
Mouhamadou M. Mbodji
ADAbdourahmane Diallo
Abdourahmane Diallo
SGSerigne M. Gueye
Serigne M. Gueye
Non-Muscle Invasive Bladder Cancer: A Review of the Current Trend in Africa

1 January 2019 in World Journal of Oncology
Verified
Journal Article
Open access
PDF file
Ayun Kotokai CassellAyun Kotokai Cassell
Ayun Kotokai Cassell
BYBashir Yunusa
Bashir Yunusa
MJMohamed Jalloh
Mohamed Jalloh
MMMouhamadou M. Mbodji
Mouhamadou M. Mbodji
ADAbdourahmane Diallo
Abdourahmane Diallo
SGSerigne M. Gueye
Serigne M. Gueye
A Review of Localized Prostate Cancer: An African Perspective

5 December 2019 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
Ayun Kotokai CassellAyun Kotokai Cassell
Ayun Kotokai Cassell
BYBashir Yunusa
Bashir Yunusa
MJMohamed Jalloh
Mohamed Jalloh
MNMedina Ndoye
Medina Ndoye
MMMouhamadou M. Mbodji
Mouhamadou M. Mbodji
SGSerigne M. Gueye
Serigne M. Gueye
The estimated incidence rate of prostate cancer in Africa was 22.0/100,000 in 2016. The International Agency for Research on Cancer (IARC) has cited prostate cancer as a growing health threat in Africa with approximated 28,006 deaths in 2010 and estimated 57,048 deaths in 2030. The exact incidence of advanced and metastatic prostate cancer is not known in sub-Saharan Africa. Hospital-based reports from the region have shown a rising trend with most patients presenting with advanced or metastatic disease. The management of advanced and metastatic prostate cancer is challenging. The available international guidelines may not be cost-effective for an African population. The most efficient approach in the region has been surgical castration by bilateral orchidectomy or pulpectomy. Medical androgen deprivation therapy is expensive and may not be available. Patients with metastatic castrate-resistant prostate cancer tend to be palliated due to the absence or cost of chemotherapy or second-line androgen deprivation therapy in most of Africa. A cost-effective guideline for developing nations to address the rising burden of advanced prostate cancer is warranted at this moment.

1 July 2020 in Research and Reports in Urology
Verified
Journal Article
Open access
PDF file
Ayun Kotokai CassellAyun Kotokai Cassell
Ayun Kotokai Cassell
MJMohamed Jalloh
Mohamed Jalloh
MNMedina Ndoye
Medina Ndoye
MMMouhamadou Mbodji
Mouhamadou Mbodji
OGOumar Gaye
Oumar Gaye
SGSerigne Gueye
Serigne Gueye
Urolithiasis is a global pathology with increasing prevalence rate. The lifetime recurrence of urolithiasis ranges from 10– 75% creating a public health crisis in affected regions. The epidemiology of urolithiasis in most parts of Africa and Asia remains poorly documented as incidence and prevalence rates in these settings are extrapolated from hospital admissions. The surgical management of kidney and ureteral stones is based on the stone location, size, the patient’s preference and the institutional capacity. To date, the available modalities in the management of urolithiasis includes external shock wave lithotripsy (ESWL), percutaneous nephrolithotomy (PCNL), ureterorenoscopy (URS) including flexible and semirigid ureteroscopy. However, regarding the lack of endourological equipment and expertise in most parts of Sub-Saharan Africa (SSA), most urological centers in these regions still consider open surgery for kidney and ureteral stones. This review explores the current trend and surgical management of upper tract urolithiasis in SSA with insight on the available clinical guidelines.

1 January 2021 in World Journal of Oncology
Verified
Journal Article
Open access
PDF file
Ayun Kotokai CassellAyun Kotokai Cassell
Ayun Kotokai Cassell
BMBurgess Manobah
Burgess Manobah
SWSoeghen Willie
Soeghen Willie
Diagnostic and Therapeutic Challenges of Rare Urogenital Cancers: Urothelial Carcinoma of the Renal Pelvis, Ureters and Urethra

1 February 2020 in Research and Reports in Urology
Verified
Journal Article
Open access
PDF file
Ayun Kotokai CassellAyun Kotokai Cassell
Ayun Kotokai Cassell
MJMohamed Jalloh
Mohamed Jalloh
MNMedina Ndoye
Medina Ndoye
BYBashir Yunusa
Bashir Yunusa
MMMouhamadou Mbodji
Mouhamadou Mbodji
SGSerigne Gueye
Serigne Gueye
Testicular cancer is a common malignancy in young males with higher incidence in developed nations but with the lowest incidence in Africa (0.3– 0.6/100 000). Ironically, the global testicular cancer mortality rate has shown a reverse trend to its incidence with higher rates in low- and middle-income countries (0.5 per 100 000) than in high-income countries. Data from GLOBOCAN 2008 have shown relatively high mortality rates in sub-Saharan countries like Mali, Ethiopia, Niger and Malawi. The prognosis of testicular tumor is good with remarkable chemosensitivity to cisplatin-based regimen. Early diagnosis, careful staging and a multidisciplinary management approach is crucial to achieve this optimal result. These results are achievable in the sub-Saharan region if the relevant resources are appropriated for cancer care and clinical guidelines are formulated in a regional context.